Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21) Concentration in Patients with Growth Hormone Deficiency (GHD)

NCT02243852 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT02243852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02243852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21) Concentration in Patients with Growth Hormone Deficiency (GHD)
Lead sponsor
University of Liverpool
Phase
Observational
Overall status
Withdrawn
Start date
September 30, 2014
Completion date
June 6, 2017
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency